Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

June 25, 2022

Study Completion Date

June 25, 2022

Conditions
ExposureHealth BehaviorEnvironment
Interventions
OTHER

HELIX's follow-up

"* Visit 1 (Day 0): clinical examination (anthropometry, bioimpedance, blood pressure,spirometry), neurodevelopment computer testing, questionnaires (Physical activity,diet, psychological distress, tobacco exposure, pubertal development, sleeping patterns, light exposure before going to sleep, outdoor environment (green spaces, noise), address history, home environment, socio-economic status, noise, psychological distress, medical history, medication use) 7 consecutive days (minimum) of personal exposure monitoring including wearing an actigraph, a Smartphone (GPS data), carrying a NO2 diffusion tube, collection of hair, stool, urines (2 urines during 6 consecutive days) and filling a sleep and physical activity diary~* Visit 2 (Day 8): blood collection early in the morning and collection of all the 7- days personal monitoring material, and stools and urines samples."

Trial Locations (1)

86000

C.H.U. de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT05158010 - Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort | Biotech Hunter | Biotech Hunter